{"id":"https://openalex.org/W1991665327","doi":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","title":"Unexpected drug\u2013drug interaction between tipranavir/ritonavir and enfuvirtide","display_name":"Unexpected drug\u2013drug interaction between tipranavir/ritonavir and enfuvirtide","alternate_titles":[],"publication_year":2006,"publication_date":"2006-09-21","ids":{"openalex":"https://openalex.org/W1991665327","doi":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","mag":"1991665327","pmid":"https://pubmed.ncbi.nlm.nih.gov/16988521"},"language":"en","primary_location":{"id":"doi:10.1097/01.aids.0000247121.19951.fa","doi":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1991665327"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058603188","display_name":"Daniel Gonz\u00e1lez de Requena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniel Gonz\u00e1lez de Requena","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039193151","display_name":"Andrea Calcagno","orcid":"https://orcid.org/0000-0003-2534-8815","observed_orcids":["https://orcid.org/0000-0003-2534-8815"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Calcagno","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107836907","display_name":"Stefano Bonora","orcid":"https://orcid.org/0000-0002-7537-3341","observed_orcids":["https://orcid.org/0000-0002-7537-3341"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Bonora","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009669838","display_name":"Laura Ladetto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Ladetto","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076836884","display_name":"Antonio D\u2019Avolio","orcid":"https://orcid.org/0000-0002-1321-4126","observed_orcids":["https://orcid.org/0000-0002-1321-4126"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio D'Avolio","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038706116","display_name":"Mauro Sciandra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mauro Sciandra","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046489228","display_name":"Marco Siccardi","orcid":"https://orcid.org/0000-0002-3539-7867","observed_orcids":["https://orcid.org/0000-0002-3539-7867"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Siccardi","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081676671","display_name":"Olivia Bargiacchi","orcid":"https://orcid.org/0009-0001-3405-8273","observed_orcids":["https://orcid.org/0009-0001-3405-8273"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Olivia Bargiacchi","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087095797","display_name":"Alessandro Sinicco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Sinicco","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107896681","display_name":"Giovanni Di Perri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Di Perri","raw_affiliation_strings":["Department of Infectious Diseases, University of Turin, Turin, Italy","Accepted 29 June, 2006","Received 14 June, 2006"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"Accepted 29 June, 2006","institution_ids":[]},{"raw_affiliation_string":"Received 14 June, 2006","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I55143463"],"apc_list":null,"apc_paid":null,"fwci":3.97,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.93448983,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"20","issue":"15","first_page":"1977","last_page":"1979"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tipranavir","display_name":"tipranavir","score":0.8550000190734863},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":1.0},{"id":"https://openalex.org/keywords/enfuvirtide","display_name":"enfuvirtide","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9810000061988831},{"id":"https://openalex.org/keywords/hiv-protease-inhibitors","display_name":"HIV protease inhibitors","score":0.7110000252723694},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5979999899864197},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.8119999766349792},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.7289999723434448},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9490000009536743},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9200000166893005},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2778037500","wikidata":"https://www.wikidata.org/wiki/Q423327","display_name":"Enfuvirtide","level":5,"score":0.9847719669342041},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8924458026885986},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5591499209403992},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5251278877258301},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47965219616889954},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4786030948162079},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3750540018081665},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.29616737365722656},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.12956511974334717},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.11184349656105042},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08628767728805542},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.07732388377189636},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.0},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.0},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000077560","descriptor_name":"Enfuvirtide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/01.aids.0000247121.19951.fa","doi":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000247121.19951.fa","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:16988521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16988521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/37344","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/37344","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2738270687","doi":null,"is_oa":false,"landing_page_url":"https://aperto.unito.it/handle/2318/111482","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320321970","display_name":"University of the Western Cape","ror":"https://ror.org/00h2vm590"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1973659740","https://openalex.org/W1999623844","https://openalex.org/W2036595571","https://openalex.org/W2063914923"],"related_works":["https://openalex.org/W4232050029","https://openalex.org/W1995221369","https://openalex.org/W2137453079","https://openalex.org/W7100106354","https://openalex.org/W2138734727","https://openalex.org/W2033007326","https://openalex.org/W2036595571","https://openalex.org/W2316292413","https://openalex.org/W1965002367"],"abstract_inverted_index":{"Fifty-five":[0],"patients":[1],"placed":[2],"on":[3],"tipranavir/ritonavir":[4],"500/200":[5],"mg":[6],"twice":[7],"a":[8,46],"day":[9],"(27":[10],"with":[11],"enfuvirtide":[12,37,67],"and":[13,18,30,50,62],"28":[14],"without)":[15],"underwent":[16],"tipranavir":[17,29,59],"ritonavir":[19,31],"plasma":[20,43],"concentration":[21],"measurements":[22],"by":[23],"high-pressure":[24],"liquid":[25],"chromatography.":[26],"Markedly":[27],"higher":[28,58],"trough":[32],"concentrations":[33],"were":[34],"observed":[35],"in":[36,66],"recipients.":[38],"The":[39],"modelling":[40],"of":[41,64],"sparse":[42],"samples":[44],"using":[45],"first":[47],"order":[48],"absorption":[49],"elimination":[51,60],"monocompartmental":[52],"model":[53],"without":[54],"time":[55],"lag":[56],"predicted":[57],"half-life":[61],"volume":[63],"distribution":[65],"takers.":[68],"This":[69],"unexpected":[70],"drug-drug":[71],"interaction":[72],"warrants":[73],"further":[74],"investigation.":[75]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1991665327","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
